The Study On Developing Strategy Of Medical Circulation Industry

The Pharmaceutical industry is called the "Evergreen industry".At present,China’s pharmaceutical industry is booming.In 2009,with the release of the policy documents like "views on the deepening of the medical and health system reform","notice on issuing the medical and health system reform focused on the implementation of the program(2009-2011)recently " of CPC Central Committee and the State Council,the new medical and health Institutional reform(new medical reform)officially began.On January 9,2017,the State Council issued the " ‘Thirteenth Five Year Plan’ on deepening the medical and health system ",marking the " 13 th Five-Year " period of China’s health reform road map officially released.As the prelude of the "thirteen five" plan,2016 for the new medical and health system reform is also a very important year to begin the plan.The implementation of the new medical reform program to the pharmaceutical market has brought disruptive changes,"two votes system" makes the pharmaceutical company which plays a key role in the pharmaceutical circulation being an embarrassing situation,to promote the flow of drugs concentrate on a small number of large national or regional leading pharmaceutical circulation Business,its traditional business model has been unable to adapt to the requirements of the new medical reform.At present,there are many problems such as management confusion,lack of functions,backward logistics and capital turnover in large number of pharmaceutical enterprises.Under the new medical reform system,the price of drugs,especially essential drugs,is declining,the distribution qualification is strict,and making the situation circulation of drugs has to be abandoned.The living space of Pharmaceutical companies has been greatly compressed,some companies have been in a situation which is difficult to operate,and this has brought adverse effects to the pharmaceutical market circulation and efficient operation.The pharmaceutical industry will face an unprecedented situation,according to the relevant industry speculation,the pharmaceutical industry is bound to be structural adjustment,and finally it will eliminate backward enterprises that can not adapt to the new situation.However,the opportunities and challenges coexist,grasp the new direction of the medical reform accurately,achieve the transformation of enterprises rapidly become the only way for the development of public pharmaceutical companies,on the basis of different types of pharmaceutical companies need to choose third-party logistics,terminal retail or third terminal distribution way to meet the needs of the market,and share a place in the pharmaceutical market under the tide of t medical reform,and get better prospects for development and profit margins.R company rooted in China’s "medicine city" known as the Z City,was established in June 2005,after years of development,has grown into a collection of wholesale,logistics,distribution and focus on drug management of large pharmaceutical distribution enterprises.First we review the strategic related theory,mainly covers the concept,characteristics and the main point of view etc.of the strategy.And then through the application of strategic management theory in the field of pharmaceutical circulation research to Jiangxi R Pharmaceutical Co.,Ltd.,from the development of R Pharmaceutical Co.,Ltd.to the environment it faces which covers the main macroeconomic environment,industry environment,the environment of business location and Internal resources and ability to begin the research,then using of PEST,SWOT and other analytical method to analyze the internal strengths and weaknesses,external opportunities and threats,and to analyze its strategic management problems and causes.According to the analysis of the results,to begin with the development strategies,we make the research about the pharmaceutical circulation enterprise for how to change the development strategy to win the survival and development under the reform of the new medical reform system.Then make a series of strategies like vertical integration,mergers and acquisitions,the domestic market expansion,strategic alliances and so on.At the same time,from the point of the human resources,management mechanisms,information management,financial management and corporate culture in four areas to ensure the smooth implementation of the strategies.It is hoped that through the analysis of R’s development path,it will be helpful to the future production and operation of related enterprises with similar experience.